Clinical trials recruiting for HIV
599
Recruiting trials
38
US states with sites
78
Countries
38%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Dolutegravir | 5 |
| Cyclophosphamide | 4 |
| VRC07-523LS | 4 |
| Varenicline | 4 |
| ChAdOx1.HIVconsv62 | 3 |
| ChAdOx1.tHIVconsv1 | 3 |
| DTG/3TC | 3 |
| Doravirine | 3 |
| Lenacapavir | 3 |
| MVA.tHIVconsv4 | 3 |
| Nicotine patch | 3 |
| BCG | 2 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 64 |
| Maryland | 57 |
| Florida | 49 |
| New York | 46 |
| Texas | 43 |
| Illinois | 28 |
| Massachusetts | 27 |
| Georgia | 26 |
| North Carolina | 26 |
| Pennsylvania | 26 |
| Alabama | 21 |
| District of Columbia | 17 |
Top cities
New York, New York 34San Francisco, California 31Baltimore, Maryland 30Houston, Texas 29Miami, Florida 29Chicago, Illinois 28Bethesda, Maryland 27Boston, Massachusetts 25Philadelphia, Pennsylvania 24Atlanta, Georgia 21
Self-screener
Recruiting trials
- #AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-implementation Trial.
- 1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
- 2DR Versus 3DR in a Prospective Randomized Controlled Switch Trial
- A Behavioral mHealth Intervention for People With HIV With Anxiety and Depression
- A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
- A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
- A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV
- A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
- A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV
- A Continued Access Study for Participants Transitioning From ViiV Healthcare-sponsored or ViiV Healthcare-collaborative Parent Studies for HIV Treatment
- A Long-term Follow-up of the HIV-NAT Cohort
- A Mobile Gaming App to Improve Adherence to PrEP
- A Multi-Level Trauma-Informed Approach to Increase HIV Pre-exposure Prophylaxis Initiation Among Black Women
- A Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia
- A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
- A Phase Ⅱa Clinical Study of CL-197 Capsules
- A Pilot Project for PLWH Aged 65-75: Preventing the Development of Frailty
- A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).
- A Randomized Clinical Trial to Evaluate Solutions for the Management of Virologic Failure on TLD in Sub-Saharan Africa
- A Registry Study on HIV-related Lymphoma
- A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIV
- A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities
- A Setting Focus Overdose Prevention Intervention
- A Social Media Intervention to Improve Retention in Care for Adolescents and Young Adults With HIV in Uganda
- A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
- A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
- A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)
- A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV
- A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV
- A Study to Evaluate JL18008 in Subject With HIV Immunological Non-Responders
- A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test
- A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
- A Study to Improve Skeletal Muscle in Veterans With HIV
- A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
- A Study to Investigate Cabotegravir for Neonates Exposed to HIV-1
- A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
- A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants
- A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments
- A Trial Testing a Two-way SMS Platform to Recognize and Prevent Wasting Among HIV-infected and HIV-exposed Uninfected Children in Kenya
- A Trial of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine, Administered to Healthy Adults Living Without and With HIV.
- A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies
- ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
- ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV
- ALS Research Collaborative
- AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)
- Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
- Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable Populations, in Non-conventional Structures "Outside the Walls" by Dual Screening Method RTDs and FibroScan®
- Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures
- Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers
- Accurate Staging of Immuno-virological Dynamics During Acute HIV Infection
- Adaptation and Implementation of an Evidence-based Approach to Advance HIV Prevention and Care
- Adaptation of an Intervention Addressing Barriers to PrEP Use Among Pregnant Women in Zimbabwe
- Adapting An Evidence-Based Intervention To Improve HIV Testing And PrEP Uptake In Vietnam
- Adapting a Stress Management Intervention to Reduce Cardiovascular Disease Risk
- Adapting and Evaluating a Tobacco Use Cessation Program for People Living With HIV in Uganda and Zambia
- Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US
- Administration of Venetoclax to Promote Apoptosis of HIV-infected Cells and Reduce the Size of the HIV Reservoir Among People Living With HIV on ART
- Advanced HIV Disease During the First Six Months on Antiretroviral Therapy in Zambia
- Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)
- Alcohol Misuse, Gut Microbial Dysbiosis and PrEP Care Continuum: Application and Efficacy of SBIRT Intervention
- Alcohol Research in HIV: Relapse Prevention
- Alcohol and "Heat of the Moment" Sexual Decision Making
- An Adaptive Randomized Controlled Trial
- An Economic and Relationship-strengthening Intervention to Reduce Alcohol Use in Malawi
- An Effectiveness Trial of the PrEP for WINGS Study
- An Enhanced Package of Care to Reduce Reduce Mortality in Advanced HIV Disease
- An Integrated Intervention Using a Pill Ingestible Sensor System
- An mHealth Intervention to Improve Outcomes for Women With HIV/AIDS
- Analyses of Newly Diagnosed HIV Infection in Hong Kong
- Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
- Antiretroviral Therapy for Acute and Chronic HIV Infection
- Antiviral Clinical Trial for Long Covid-19
- Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies
- Appalachian Partnership to Reduce Disparities (Aim 2)
- Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants
- Assessing Pharmacy Technician Educational Training for the Provision of Over-the-Counter Hearing Aids in Rural Alabama and Mississippi Pharmacies
- Assessing the Effects of a Multisectoral Agricultural Intervention on the Reproductive and Sexual Health of Adolescent Girls and Young Women
- Assessing the Feasibility of Coach Mpilo for Men With TB and HIV
- Assessing the Use of MY-RIDE, a Just-in-time Adaptive Intervention, to Improve HIV Prevention and Substance Use in Youth Experiencing Homelessness
- Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use
- Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique
- Association Between Human Immunodeficiency Virus (HIV) Infection and Male Hypogonadism
- Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
- Augmented Renal Clearance in Neurocritical Care
- B-PaLMZ for TB Meningitis
- B. Infantis Supplementation to Improve Immunity in Infants Exposed to HIV
- B.R.A.I.N in People Living With HIV Study
- BEYOND Study: Improving HIV Treatment and Well-Being Among Young MSM in Vietnam
- BIG Chicago: A Trial of Basic Income Guarantee for Young People Living With HIV
- BRAZILIAN REGISTRY OF CHRONIC NON-COMMUNICABLE DISEASES IN PEOPLE LIVING WITH HIV/AIDS
- Baricitinib for Reduction of HIV - CNS
- Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB
- Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults
- Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority Individuals
- Behavioral Risk Identification and Decision Guidance for HIV Engagement
- Behavioral and Psychosocial Characteristics of Clients Accessing Services at IHRI
- BetterInfo on Women's PrEP Choices and Outcomes in Malawi
- Blood Collection Biorepository for Liver Disease Research
- Boosting Olfactory and Sensory Training Study (BOOST)
Related conditions
Trials recruiting for HIV often also study these conditions. Each links to its own recruiting-trial list.
HIV Prevention 32HIV/AIDS 24Human Immunodeficiency Virus 18Depression 1463Substance Use 18HIV (Human Immunodeficiency Virus) 11Hepatitis B 147Tuberculosis 14Obesity 1512Kaposi Sarcoma 12
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for HIV trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.